Absorption, kinetics, antibody-bound and free serum determination of a 14C-labeled Escherichia coli extract after single oral administration in rats. 1997

A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
Research & Consulting Company Umweltchemie AG, Department of Biochemistry, Itingen, Switzerland.

The bioavailability of the major fraction of a 14C-labeled Escherichia coli extract (OM-89) of high molecular mass > 30 kD (HEC) was investigated in rats after a single oral administration of a dose of 100 mg/kg b.w. The determination of radioactivity in blood and plasma showed that HEC was absorbed by the digestive tract, either in its original form or partly degraded. In plasma, the radioactivity reached a Cmax value after 4 h, equivalent to an extract concentration of 31.7 micrograms/g of plasma with an elimination half live of 33 h. High molecular weight molecules of HEC (> 30 kD) were found by radiochromatography in rat serum 4 h after administration. Immunoprecipitation in the serum showed that HEC retains intact determinants throughout the digestive and absorptive processes. It is therefore absorbed either in its original form or partly degraded. A high incorporation of radiolabel was found in liver, secretory glands (adrenals, thyroid gland, pancreas), and in lymphoid organs (spleen, mesenteric lymph nodes).

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial

Related Publications

A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
March 1997, Arzneimittel-Forschung,
A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
June 1968, The Biochemical journal,
A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
April 1994, Arzneimittel-Forschung,
A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
October 1993, Arzneimittel-Forschung,
A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
May 1976, Toxicology and applied pharmacology,
A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
January 2022, Xenobiotica; the fate of foreign compounds in biological systems,
A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
September 1966, American journal of epidemiology,
A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
April 1994, Arzneimittel-Forschung,
A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
February 1974, British journal of pharmacology,
A van Dijk, and J Bauer, and E A Sedelmeier, and W G Bessler
November 1988, Arzneimittel-Forschung,
Copied contents to your clipboard!